Scientech Research LLC Buys Shares of 33,981 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Scientech Research LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 33,981 shares of the medical instruments supplier's stock, valued at approximately $846,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Wahed Invest LLC boosted its holdings in DENTSPLY SIRONA by 9.3% during the 4th quarter. Wahed Invest LLC now owns 3,603 shares of the medical instruments supplier's stock valued at $128,000 after acquiring an additional 306 shares during the period. Raymond James Trust N.A. grew its holdings in shares of DENTSPLY SIRONA by 4.9% in the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier's stock worth $241,000 after purchasing an additional 453 shares during the last quarter. LRI Investments LLC raised its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier's stock valued at $31,000 after buying an additional 564 shares during the last quarter. Diversified Trust Co boosted its position in DENTSPLY SIRONA by 3.0% during the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier's stock valued at $489,000 after buying an additional 566 shares during the period. Finally, Epoch Investment Partners Inc. increased its position in shares of DENTSPLY SIRONA by 2.2% in the second quarter. Epoch Investment Partners Inc. now owns 30,169 shares of the medical instruments supplier's stock valued at $752,000 after acquiring an additional 647 shares during the period. Hedge funds and other institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Stock Up 2.6 %

DENTSPLY SIRONA stock traded up $0.70 on Friday, hitting $27.05. 2,027,562 shares of the stock traded hands, compared to its average volume of 3,057,677. The business's fifty day simple moving average is $25.54 and its 200 day simple moving average is $27.56. The firm has a market cap of $5.48 billion, a P/E ratio of -61.48, a price-to-earnings-growth ratio of 1.25 and a beta of 1.00. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA Inc. has a 1 year low of $23.58 and a 1 year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to the consensus estimate of $993.61 million. During the same period in the previous year, the firm earned $0.51 EPS. The company's revenue was down 4.3% on a year-over-year basis. As a group, sell-side analysts forecast that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.37%. The ex-dividend date is Friday, September 27th. DENTSPLY SIRONA's payout ratio is -145.45%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. Barrington Research reissued an "outperform" rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, September 20th. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a research report on Thursday, July 18th. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a "neutral" rating for the company in a report on Monday, July 22nd. Needham & Company LLC reaffirmed a "buy" rating and issued a $34.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Finally, Evercore ISI reduced their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an "outperform" rating on the stock in a research report on Tuesday, July 9th. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $33.22.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.